ChemicalBook >> CAS DataBase List >>Infliximab
Infliximab
- CAS No.
- 170277-31-3
- Chemical Name:
- Infliximab
- Synonyms
- Infiximab;Remicade;Avakine;CT-P 13;Unii-B72hh48flu;Infliximab solution;Infliximab 6.1mg/mg;Infliximab USP/EP/BP;Infliximab (10 mg/ml);Infliximab(170277-31-3)
- CBNumber:
- CB01116807
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MFCD06795259
- MOL File:
- Mol file
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-07-27 17:00:41
| storage temp. | Store at -30°C |
|---|---|
| form | Solid |
| color | White to off-white |
| Major Application | pharmaceutical |
| FDA UNII | B72HH48FLU |
| NCI Drug Dictionary | Remicade |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| WGK Germany | WGK 3 |
|---|---|
| Storage Class | 11 - Combustible Solids |
| Hazardous Substances Data | 170277-31-3(Hazardous Substances Data) |
Infliximab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | FI139130 | Infliximab (10 mg/ml) | 170277-31-3 | 5mg | $480.45 | 2026-06-04 | Buy |
| Biosynth | FI139130 | Infliximab (10 mg/ml) | 170277-31-3 | 10mg | $672.6 | 2026-06-04 | Buy |
| Biosynth | FI139130 | Infliximab (10 mg/ml) | 170277-31-3 | 25mg | $961 | 2026-06-04 | Buy |
| Biosynth | FI139130 | Infliximab (10 mg/ml) | 170277-31-3 | 50mg | $1537.5 | 2026-06-04 | Buy |
| Biosynth | FI139130 | Infliximab (10 mg/ml) | 170277-31-3 | 100mg | $2308 | 2026-06-04 | Buy |
Infliximab Chemical Properties, Uses, Production
Uses
Infliximab targets the transcription factor NF-κB with harmine and related compounds for treatment of cancers and inflammatory diseases and combination with other agents
in vivo
A single injection of Infliximab (10 μg/g in 100 μL saline/dose ip) in diabetic TNF-α+/+) mice leads to suppression of the increased serum TNF-α and amelioration of the electrophysiological and biochemical deficits for at least 4 weeks. The increased TNF-α mRNA expression in diabetic dorsal root ganglion is also attenuated by Infliximab[2].
Infliximab Preparation Products And Raw materials
Raw materials
Preparation Products
Infliximab Suppliers
Global Suppliers ( 115)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hefei Hirisun Pharmatech Co., Ltd. | +86-0551-62678551 15056975894 | sales@hirisunpharm.com | China | 147 | 55 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
| LGM Pharma | 1-(800)-881-8210 | inquiries@lgmpharma.com | United States | 2110 | 70 |
| Wuhan Sunrise Technology Development Co., Ltd. | 27-027-83314682 13554138826 | whsrtech@vip.163.com | China | 140 | 62 |
| Wuhan Fortuna Chemical Co., Ltd | 027-59207852 13308628970 | buy@fortunachem.com | China | 2684 | 58 |
| Dalian Meilun Biotech Co., Ltd. | 0411-62910999 13889544652 | sales@meilune.com | China | 4765 | 58 |
| Nanjing Sunlida Biological Technology Co., Ltd. | 025-57798810 18652991625 | sales@sunlidabio.com | China | 3223 | 55 |
| Sichuan Wei Keqi Biological Technology Co., Ltd. | 028-81700200 18116577057 | 3003855609@qq.com | China | 7717 | 56 |
| Shanghai Macklin Biochemical Co.,Ltd. | 15221275939 15221275939 | shenlinxing@macklin.cn | China | 15775 | 55 |
| Taizhou KEDE Chemical Co., Ltd | 0576-84613060 13093829633;13736603231; | sales@kedechemical.com | China | 299 | 60 |
View Latest Price from Infliximab manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-09-14 | Infliximab
170277-31-3
|
1kg | 98% | 20tons | Sinoway Industrial co., ltd. | ||
![]() |
2026-08-20 | Infliximab USP/EP/BP
170277-31-3
|
$1.10 | 1g | 99.9% | 100 Tons Min | Dideu Industries Group Limited | |
![]() |
2026-07-27 | Infliximab
170277-31-3
|
$98.00-273.00 | 98.00% | 10g | TargetMol Chemicals Inc. |
-

- Infliximab
170277-31-3
- 98%
- Sinoway Industrial co., ltd.
-

- Infliximab USP/EP/BP
170277-31-3
- $1.10
- 99.9%
- Dideu Industries Group Limited
-

- Infliximab
170277-31-3
- $98.00-273.00
- 98.00%
- TargetMol Chemicals Inc.
170277-31-3 (Infliximab) Related Search:
Avakine
Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal ca2 heavy chain), disulfide with human-mouse monoclonal ca2 light chain, dimer
Unii-B72hh48flu
CT-P 13
Infliximab USP/EP/BP
Research Grade Infliximab(DHB94403)
TNFR1,Infliximab,anti-inflammatory,Avakine,Tumor Necrosis Factor Receptor,autoimmune,diabetic,TNFR,PTP1B,neuropathy,Inhibitor,TNFR2,monoclonal,TNF Receptor,inhibit,CT-P13
Infliximab (anti-TNF-alpha)
Research Grade Infliximab
Infliximab solution
Infliximab (10 mg/ml)
Infliximab 6.1mg/mg
Infliximab(170277-31-3)
Infiximab
Remicade
Infliximab (Anti-TNF-α)
170277-31-3




